What is the treatment for hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatment of hypercalcemia depends on its severity, underlying cause, and symptoms, and the most effective approach includes aggressive intravenous fluid rehydration, loop diuretics, and bisphosphonates, with zoledronic acid being the preferred option, as recommended by the NCCN Panel members 1.

Overview of Hypercalcemia Treatment

The treatment of hypercalcemia is guided by its severity and the underlying cause. For mild cases, observation and hydration may suffice, but for moderate to severe cases, a more aggressive approach is necessary.

Initial Management

Initial management includes:

  • Aggressive intravenous fluid rehydration with normal saline at 200-300 mL/hour to restore intravascular volume and enhance renal calcium excretion.
  • Loop diuretics like furosemide (20-40 mg IV every 12 hours) can be added to prevent fluid overload and further increase calcium excretion.

Bisphosphonates and Other Therapies

For severe hypercalcemia (>14 mg/dL) or symptomatic cases, bisphosphonates are the mainstay of treatment, with:

  • Zoledronic acid (4 mg IV over 15 minutes) being the most effective option, as it inhibits osteoclast-mediated bone resorption 1.
  • Calcitonin (4-8 IU/kg SC/IM every 12 hours) provides rapid but short-term calcium reduction and can be used while waiting for bisphosphonates to take effect.
  • Denosumab (120 mg SC) may be used in malignancy-related hypercalcemia, especially in renal impairment.
  • Glucocorticoids like prednisone (40-60 mg daily) are effective for hypercalcemia caused by certain malignancies or granulomatous diseases.

Additional Considerations

Dialysis may be necessary in severe cases with renal failure. Treating the underlying cause, such as primary hyperparathyroidism or malignancy, is crucial for long-term management of hypercalcemia. The NCCN guidelines provide a comprehensive approach to managing hypercalcemia, emphasizing the importance of individualized treatment based on the severity and cause of hypercalcemia 1.

From the FDA Drug Label

  1. 2 Treatment of Hypercalcemia Calcitonin-salmon injection is indicated for the early treatment of hypercalcemic emergencies, along with other appropriate agents, when a rapid decrease in serum calcium is required, until more specific treatment of the underlying disease can be accomplished It may also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or corticosteroids, or other agents.
  2. 2 Hypercalcemia The recommended starting dose of calcitonin-salmon injection for early treatment of hypercalcemia is 4 International Units/kg body weight every 12 hours by subcutaneous or intramuscular injection. If the response to this dose is not satisfactory after one or two days, the dose may be increased to 8 International Units/kg every 12 hours If the response remains unsatisfactory after two more days, the dose may be further increased to a maximum of 8 International Units/kg every 6 hours.

The treatment for hypercalcemia includes calcitonin-salmon injection as an early treatment option, often used in conjunction with other agents such as:

  • Intravenous fluids
  • Furosemide
  • Oral phosphate
  • Corticosteroids The recommended starting dose of calcitonin-salmon injection is 4 International Units/kg body weight every 12 hours, with possible dose increases to 8 International Units/kg every 12 hours or 8 International Units/kg every 6 hours if the initial response is unsatisfactory 2.

From the Research

Treatment Options for Hypercalcemia

The treatment for hypercalcemia depends on the underlying cause and severity of the condition. Some of the treatment options include:

  • Hydration and intravenous bisphosphonates, such as zoledronic acid or pamidronate, for symptomatic or severe hypercalcemia 3, 4, 5, 6
  • Parathyroidectomy for primary hyperparathyroidism (PHPT) 3, 4
  • Glucocorticoids for hypercalcemia due to lymphoma or granulomatous diseases 4, 6
  • Denosumab for refractory cases of hypercalcemia 5, 7
  • Calcitonin for immediate short-term management of severe symptomatic hypercalcemia 4, 5, 6, 7
  • Loop diuretics for individuals with renal insufficiency or heart failure to prevent fluid overload 6
  • Dialysis for severe hypercalcemia complicated with kidney failure 6

Medications Used to Treat Hypercalcemia

Some of the medications used to treat hypercalcemia include:

  • Bisphosphonates: zoledronic acid, pamidronate, etidronate, clodronate, ibandronate 4, 5
  • Calcitonin 4, 5, 6, 7
  • Glucocorticoids 4, 6
  • Denosumab 5, 7
  • Gallium nitrate 4, 7

Treatment Approach

The treatment approach for hypercalcemia involves:

  • Identifying and treating the underlying cause of hypercalcemia 3, 4, 5, 6, 7
  • Managing symptoms and preventing complications 3, 4, 5, 6, 7
  • Monitoring serum calcium levels and adjusting treatment as needed 3, 4, 5, 6, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypercalcemia: A Review.

JAMA, 2022

Research

Current management strategies for hypercalcemia.

Treatments in endocrinology, 2003

Research

Treatment of chronic hypercalcemia.

Medicinal chemistry (Shariqah (United Arab Emirates)), 2012

Research

Hypercalcemia: an evidence-based approach to clinical cases.

Iranian journal of kidney diseases, 2009

Research

Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.